A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities

Código QR

A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities

Xuemei Liao,1,* Hui Ye,2,* Tianmei Si1 1Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, 100191, People&rsqu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liao X, Ye H, Si T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	antipsychotics switch metabolic syndrome Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/2bc95ce15fe142eda43fbcfdde51a676
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
por: Fang X, et al.
Publicado: (2019)

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
por: Porfirio MC, et al.
Publicado: (2017)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
por: Boiko AS, et al.
Publicado: (2020)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2020)

Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study
por: Kiwan N, et al.
Publicado: (2019)

Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia
por: Teshome T, et al.
Publicado: (2020)

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2016)

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
por: Xu H, et al.
Publicado: (2019)

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
por: Citrome L, et al.
Publicado: (2019)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
por: Wani RA, et al.
Publicado: (2015)

Esquizofrenia y su asociación con enfermedades médicas crónicas
por: Orellana,Gricel, et al.
Publicado: (2017)

Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
por: Rachael K. Blackman, et al.
Publicado: (2022)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari J, et al.
Publicado: (2013)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
por: Wani RA, et al.
Publicado: (2015)

Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study
por: Huang YC, et al.
Publicado: (2018)

Metabolic screening and its impact in children with non-syndromic intellectual disability
por: Ali YF, et al.
Publicado: (2017)

Alteraciones metabólicas asociadas al uso de terapia antipsicótica
por: Rojas G,Paula, et al.
Publicado: (2009)

Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia
por: Suttajit S, et al.
Publicado: (2013)

Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review
por: Zhang LL, et al.
Publicado: (2016)

Metabolic Syndrome Predicts Poor Outcome in Acute Ischemic Stroke Patients After Endovascular Thrombectomy
por: Chen Z, et al.
Publicado: (2020)

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
por: Ward K, et al.
Publicado: (2019)

Antipsychotics and risk of natural death in patients with schizophrenia
por: Chen Y, et al.
Publicado: (2019)

COMPARISON OF TWO WIDELY USED ATYPICAL ANTIPSYCHOTICS OLANZAPINE VERSUS RISPERIDONE IN TERMS OF METABOLIC OUTCOMES
por: Shiraz Hussain, et al.
Publicado: (2021)

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia
por: Sicras-Mainar A, et al.
Publicado: (2014)

Diabetology & metabolic syndrome

A High Incidence of Metabolic Syndrome Traits in Mexicans Points at Obesity-Related Metabolic Dysfunction
por: Bello-Chavolla OY, et al.
Publicado: (2021)

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
por: Takeshima M, et al.
Publicado: (2018)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
por: Montemagni C, et al.
Publicado: (2016)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
por: Leonid Mikhaylovich Bardenshteyn, et al.
Publicado: (2010)

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publicado: (2009)

Models for estimating the metabolic syndrome biological age as the new index for evaluation and management of metabolic syndrome
por: Kang YG, et al.
Publicado: (2017)

Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders
por: Emilia Vassilopoulou, et al.
Publicado: (2021)

Metabolic syndrome: some results and prospects for solving the problem
por: X. Chu, et al.
Publicado: (2016)

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study
por: Horsdal HT, et al.
Publicado: (2017)

Evaluation of Eight Anthropometric Indices for Identification of Metabolic Syndrome in Adults with Diabetes
por: Guo X, et al.
Publicado: (2021)

Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk
por: Togfano RJ, et al.
Publicado: (2020)

Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia
por: Chen X, et al.
Publicado: (2021)

Lack of tolerable treatment options for patients with schizophrenia
por: Citrome L, et al.
Publicado: (2015)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose M, et al.
Publicado: (2021)

Metabolic syndrome: Contradictions and Concensuses (based on the materials of IV International Congress Prediabetes and Metabolic Syndrome, Madrid, 6-9 April 2011)
por: Olga Konstantinovna Vikulova
Publicado: (2011)